Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
print logo

Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2016

ResearchMoz presents this most up-to-date research on Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2016.
Harsha Mohata | 12.01.2017

DelveInsight's, "Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2016" discusses the global insulin biosimilar industry. Report analyzes that Insulin and Insulin Biosimilars holds a future scope and potential in the market. It highlights the market trends, regulatory requirements for US and EU and key domestic players.

Report provides an insight on Insulin Biosimilars that are under development for Type 1 and Type 2 Diabetes with an insight on the Epidemiology of the disease. It provides detailed information on the 11 Insulin Biosimilar that are in pipeline.

It analyses Insulin Biosimilar industry and discusses the key market trends, major players, market assessment of 6 marketed insulin and the types of insulin with the length activity available in market. Report provides an update on the recent collaborations occurring in the insulin biosimilar market and the companies looking for partnership for the same.

Scope

    Coverage of global insulin biosimilar under development across the globe
    Sales forecast for marketed insulin from 2015 to 2017
    Detailed information on product description and related stage of development, the mode of therapy, mechanism of action, development partner and technology information.
    The report discusses the biosimilar regulatory landscape of various markets including developed markets of the US and EU
    Report analyses the types of insulin under development with respect to their market share and length of activity

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=655798

Table of Content

Executive Summary
Biosimilar
History of Insulin and Insulin Biosimilar Development
Regulatory Pathways in US and EU
Illustration of the Originator and Biosimilar Development
Major Indication
Epidemology
Complications Associated with Diabetes
Diagnosis of Diabetes
Analysis
Clinical Trials
Technology
Market Assessment
Market Trends
Drivers
Barriers
Historical Sales Data for the Marketed Drugs
Forecasted Sales Data for the Marketed Drugs
Major Competitors

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://latestmedicalrelatedresearchreport.blogspot.in/

About the tenderer: Harsha Mohata